Evaluation Of The Success Rate of NOVAMag® SHIELD
Recruiting
Phase 4
Interventional Study
Alveolar Buccal Bone Dehiscences
Socket Type 3 Subclass B
Socket Type 3 Subclass C
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Egas Moniz - Cooperativa de Ensino Superior, CRL · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study hypothesizes that the SHIELD technique, when combined with a suitable bone graft material, enables successful immediate implant placement in Type 3 extraction sockets with buccal bone dehiscence, regardless of the extent of buccal bone loss. Specifically, it is proposed that the regenerative potential of the SHIELD technique is not significantly affected by the degree of buccal bone deh…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older;
* Willingness and ability to provide informed consent and accept participation in the study.
* Presence of a tooth indicated for extraction in the aesthetic zone (including premolars);
* Clinical indication for immediate implant placement followi…
Contacts